Application of clinical trial inclusion criteria to clinical practice patients to quantify the burden of CNS metastases on health-related quality of life and healthcare resource use in patients with NSCLC
Lung Cancer(2020)
Abstract
•Clinical practice data on the burden of CNS disease in NSCLC.•No decline in quality of life over 3 months in patients with/without CNS metastases.•Minor differences in quality of life and resource use observed between cohorts.•Differences focussed on comorbidities, diagnostic tests and length of hospital stay.•Supportive of clinical trial inclusion of well-selected patients with CNS disease.
MoreTranslated text
Key words
CNS metastases,Healthcare resource use,Health-related QoL,NSCLC,Clinical practice
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined